Entities / Entity
Broad Institute.
biomedical and genomic research center
- Reports this week
- 1
- Active events
- 0
- Connections
- 597
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
Robert Plenge holds various appointments, including Chief Research Officer at Bristol-Myers Squibb, and serves on the boards of BioMarin Pharmaceutical and the PhRMA Foundation.Some support1 report
-
Feng Zhang and Eric S. Lander were founding members and top-dollar contributors to the Broad Institute as of August 29, 2026.Some support2 reports
One to three months ago
-
Researchers led experimental gene-editing trials at Shanghai Jiao Tong University and developed base-editing technology at the Broad Institute.Some support2 reports1 development inside
-
AHC collaborates with Jackson Laboratory and Broad Institute on the PERC gene editing project.Some support2 reports
Gone quiet
No new reports in 90+ days-
Broad Institute partnered with Zoo New England on June 1, 2026.Some support1 report
-
Broad Institute validates a new test for colorectal cancer recurrence monitoring, alongside reports that tariffs benefit AI stocks.Speculative1 report
-
Regeneron Pharmaceuticals awarded a prize to Sreekar Mantena, an MIT candidate and Broad Institute nominee, who works under Soumya Raychaudhuri.Some support2 reports
-
Editas Medicine became the exclusive licensee of Broad Institute's Cas12a patent estate.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Broad Institute this week
News at the entities that move Broad Institute most-
Google DeepMind OperationalNoam Shazeer joins OpenAI to advance AI efforts as Google and Meta compete in generative AI.Moves Broad Institute
Connections
The 6 strongest of 597, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Eric S. Lander Structural
Eric S. Lander served as a founding director and core institute member of the Broad Institute.
-
Editas Medicine Structural
Editas Medicine is an exclusive licensee of patents and patent estates held by the Broad Institute.
-
Jackson Laboratory Operational
The two institutions actively partner on research projects, including the PERC project and genetic medicine development.
-
Feng Zhang Structural
Feng Zhang is a top-dollar financial contributor to the Broad Institute.
-
Google DeepMind Operational
The two entities are actively collaborating, with Google DeepMind contributing scientific input to the research resources of the Broad Institute.
-
David Liu Structural
David Liu developed base-editing technology while affiliated with the Broad Institute.
History
Events by the month they beganSeptember 2026
2 events- Robert Plenge holds various appointments, including Chief Research Officer at Bristol-Myers Squibb, and serves on the boards of BioMarin Pharmaceutical and the PhRMA Foundation.
- Feng Zhang and Eric S. Lander were founding members and top-dollar contributors to the Broad Institute as of August 29, 2026.
July 2026
2 eventsJune 2026
4 events- Broad Institute partnered with Zoo New England on June 1, 2026.
- Broad Institute validates a new test for colorectal cancer recurrence monitoring, alongside reports that tariffs benefit AI stocks.
- Regeneron Pharmaceuticals awarded a prize to Sreekar Mantena, an MIT candidate and Broad Institute nominee, who works under Soumya Raychaudhuri.
- Editas Medicine became the exclusive licensee of Broad Institute's Cas12a patent estate.